Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Depreciation & Amortization (CF): 2014-2025

Historic Depreciation & Amortization (CF) for MediWound (MDWD) over the last 8 years, with Jun 2025 value amounting to $358,000.

  • MediWound's Depreciation & Amortization (CF) fell 2.72% to $358,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 million, marking a year-over-year increase of 2.21%. This contributed to the annual value of $1.5 million for FY2024, which is 13.81% up from last year.
  • Latest data reveals that MediWound reported Depreciation & Amortization (CF) of $358,000 as of Q2 2025, which was down 2.72% from $368,000 recorded in Q2 2024.
  • Over the past 5 years, MediWound's Depreciation & Amortization (CF) peaked at $368,000 during Q2 2024, and registered a low of $276,000 during Q4 2021.
  • In the last 3 years, MediWound's Depreciation & Amortization (CF) had a median value of $336,500 in 2023 and averaged $336,000.
  • As far as peak fluctuations go, MediWound's Depreciation & Amortization (CF) climbed by 23.21% in 2021, and later declined by 5.61% in 2023.
  • Quarterly analysis of 5 years shows MediWound's Depreciation & Amortization (CF) stood at $276,000 in 2021, then rose by 3.13% to $329,000 in 2022, then dropped by 4.26% to $315,000 in 2023, then grew by 16.83% to $368,000 in 2024, then declined by 2.72% to $358,000 in 2025.
  • Its Depreciation & Amortization (CF) was $358,000 in Q2 2025, compared to $368,000 in Q2 2024 and $315,000 in Q2 2023.